ript>

For adults with cHL whose cancer
has come back or spread after an autologous
stem cell transplant and treatment with
Adcetris® (brentuximab vedotin) or after
3 or more kinds of treatment including
an autologous stem cell transplant

Clinical Trial Results

Proven in Clinical Trials

When given OPDIVO
69%
or 179 of 258 patients had their tumors shrink or disappear completely
55 %
(142 of 258) saw their tumors shrink
(partial response)
14 %
(37 of 258) saw their tumors disappear completely
(complete response)

 

The clinical trials are ongoing.

About the Clinical Trials

OPDIVO was studied in and results were combined from two different clinical trials, which included
258 adult cHL patients whose cancer had come back
or spread after autologous stem cell transplant.
Most of these patients also had treatment with Adcetris® (brentuximab vedotin).

The two studies were designed to look at overall response rate and duration of response. Overall response rate is the percentage of patients who responded to treatment. These patients saw their tumors either shrink or disappear completely. The duration of response is the measure of how long the response lasts.

OPDIVO will not work for everyone. Individual results may vary.



How Long Did Patients Respond to OPDIVO in the Clinical Trials?

Of the 179 patients who responded

Of those who responded, 69% or 179 of 258 patients
were still responding to treatment when the data
were collected.

With an average follow-up time of 6.7 months,
more than half of the patients who responded to OPDIVO
were still responding in the clinical trials.

The clinical trials are ongoing.


Select Important Facts

What are the serious side effects of OPDIVO?

OPDIVO can cause problems that can sometimes become serious or
life-threatening and can lead to death. Serious side effects may include lung problems (pneumonitis); intestinal problems (colitis) that can lead to tears or holes in your intestine; liver problems (hepatitis); hormone gland problems (especially the thyroid, pituitary, adrenal glands, and pancreas); kidney problems, including nephritis and kidney failure; skin problems; inflammation of the brain (encephalitis); problems in other organs; severe infusion reactions: and complications of stem cell transplant that uses donor stem cell cells (allogenic) after treatment with OPDIVO.


Of the 258 patients included from the two clinical trials,
a smaller group of 95 patients was also studied.
These patients previously had an autologous
stem cell transplant and received
Adcetris® (brentuximab vedotin) after the transplant.

When given OPDIVO
66%
(63 of 95) saw an improvement in
their condition with OPDIVO

60 %
(57 of 95) saw tumors shrink
(partial response)
6 %
(6 of 95) saw tumors disappear completely
(complete response)

In this group of 95 patients, half of the 63 patients
who responded to OPDIVO saw tumors shrink
or disappear for at least

13.1 months

(median duration of response was
13.1 months:
range 0.0+ to 23.1+ months)

OPDIVO will not work for everyone. Individual results
may vary.


What are the most common side effects of OPDIVO?

The most common side effects of OPDIVO when used alone include:

  • feeling tired
  • pain in muscles, bones, and joints
  • diarrhea
  • weakness
  • shortness of breath
  • decreased appetite
  • upper respiratory tract infection
  • headache
  • rash
  • itchy skin
  • nausea
  • cough
  • constipation
  • back pain
  • fever
  • stomach pain

These are not all of the possible side effects of OPDIVO. Talk to your healthcare team for more information. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch or
call 1-800-FDA-1088.
You may also
report side effects to Bristol-Myers Squibb at 1-800-721-5072.

Talking with your doctor is key

Review a list of questions with your oncologist about whether
OPDIVO is right for you.

Talk to Your Doctor

Complimentary support, tools, and educational resources for anyone considering or currently taking OPDIVO. Call 1-855-OPDIVO-1 or click to learn more.

Sign Up Now

SELECT IMPORTANT FACTS ABOUT OPDIVO

OPDIVO can cause problems that can sometimes become serious or life-threatening and can lead to death. Serious side effects may include lung problems (pneumonitis); intestinal problems (colitis) that can lead to tears or holes in your intestine; liver problems (hepatitis); hormone gland problems (especially the thyroid, pituitary, adrenal glands, and pancreas); kidney problems, including nephritis and kidney failure; skin problems; inflammation of the brain (encephalitis); problems in other organs; severe infusion reactions; and complications of stem cell transplant that uses donor stem cells (allogeneic) after treatment with OPDIVO. The most common side effects of OPDIVO when used alone include: feeling tired; pain in muscles, bones, and joints; diarrhea; weakness; shortness of breath; decreased appetite; upper respiratory tract infection; headache; rash; itchy skin; nausea; cough; constipation; back pain; fever; and stomach pain.

Important Facts About
OPDIVO® (nivolumab)

This is a summary of important information that you need to know about OPDIVO. Your healthcare team can work with you to help answer any questions you may have about OPDIVO. Keep this information in a safe place so you can refer to it before and during your treatment.

Look out for the following icons as you read:

  • Talk to your
    healthcare team
  • Call a healthcare
    provider right away
  • Helpful information
    to remember

What is OPDIVO?

OPDIVO is a prescription medicine used to treat adults who have a type of blood cancer called classical Hodgkin Lymphoma, and who:

Have classical Hodgkin Lymphoma that has come back or spread after a type of stem cell transplant that uses their own stem cells (autologous stem cell transplant); AND

Used the drug brentuximab vedotin (Adcetris®) before or after the stem cell transplant; OR

Received at least 3 kinds of treatment including an autologous stem cell transplant.

OPDIVO was approved based on response rate. There is ongoing evaluation of clinical benefit of OPDIVO for this use.

It is not known if OPDIVO is safe and effective in children less than 18 years of age.

OPDIVO is a medicine that may treat certain cancers by working with your immune system. It can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way these organs work.


What are the serious side effects of OPDIVO?

A serious side effect is a side effect that can sometimes become life-threatening and can lead to death. They may happen anytime during treatment or even after your treatment has ended.

Get medical help immediately if you develop any of these symptoms or they get worse. It may keep these problems from becoming more serious. Your healthcare team will check you for side effects during treatment with OPDIVO, and may treat you with corticosteroid or hormone replacement medicines. If you have a serious side effect, your healthcare team may need to delay or completely stop your treatment.

Lung problems (pneumonitis) – Things to look out for may include:

  • new or worsening cough
  • chest pain
  • shortness of breath

Intestinal problems (colitis) that can lead to tears or holes in your intestine – Things to look out for may include:

  • diarrhea (loose stools) or more
    bowel movements than usual
  • blood in your stools or dark,
    tarry, sticky stools
  • severe stomach area (abdomen)
    pain or tenderness

Liver problems (hepatitis) – Things to look out for may include:

  • yellowing of your skin or
    the whites of your eyes
  • severe nausea or vomiting
  • pain on the right side of your
    stomach area (abdomen)
  • drowsiness
  • dark urine (tea colored)
  • bleeding or bruising more easily
    than normal
  • feeling less hungry than usual
  • decreased energy

Hormone gland problems (especially the thyroid, pituitary, adrenal glands, and pancreas) – Things to look out for may include:

  • headaches that will not go away
    or unusual headaches
  • extreme tiredness
  • weight gain or weight loss
  • changes in mood or behavior,
    such as decreased sex drive,
    irritability, or forgetfulness
  • hair loss
  • feeling cold
  • constipation
  • voice gets deeper
  • excessive thirst or lots of urine

Kidney problems, including nephritis and kidney failure – Things to look out for may include:

  • decrease in the amount of urine
  • blood in your urine
  • swelling in your ankles
  • loss of appetite

Skin problems – Things to look out for may include:

  • rash
  • itching
  • skin blistering
  • ulcers in the mouth or other
    mucous membranes

Inflammation of the brain (encephalitis) – Things to look out for may include:

  • headache
  • fever
  • tiredness or weakness
  • confusion
  • memory problems
  • sleepiness
  • seeing or hearing things that are not really there (hallucinations)
  • seizures
  • stiff neck

Problems in other organs – Things to look out for may include:

  • changes in eyesight
  • severe or persistent
    muscle or joint pains
  • severe muscle weakness
  • chest pain

Severe infusion reactions – Things to look out for may include:

  • chills or shaking
  • itching or rash
  • flushing
  • difficulty breathing
  • dizziness
  • fever
  • feeling like passing out

Talk to your healthcare team right away if you get any of the symptoms of a severe infusion reaction during or after an infusion of OPDIVO.

Stem cell transplant complications are possible if you receive donor stem cells (allogeneic stem cell transplant) after treatment with OPDIVO. These complications can be severe and can lead to death. Your healthcare team will monitor you for signs of complications if you have an allogeneic stem cell transplant.


What should I discuss with my healthcare team about pregnancy and nursing before starting OPDIVO?

Tell your healthcare team if you are pregnant or plan to become pregnant. OPDIVO can harm your unborn baby. Females who are able to become pregnant should use an effective method of birth control during and for at least 5 months after the last dose of OPDIVO.

Talk to your healthcare team about birth control methods that you can use during this time. Tell your healthcare team right away if you become pregnant during treatment.

Tell your healthcare team if you are breastfeeding or plan to breastfeed. It is not known if OPDIVO passes into your breast milk. Do not breastfeed during treatment.


What should I discuss with my healthcare team before starting OPDIVO?

Talk to your healthcare team about all of your health problems or concerns, including if you:

  • have immune system
    problems such as Crohn’s disease, ulcerative colitis, or lupus
  • have had an organ transplant
  • have lung or breathing problems
  • have liver problems
  • have any other medical conditions

Talk to your healthcare team about all of the medicines you are taking, including:

  • prescription medicines
  • over-the-counter medicines
  • vitamins
  • herbal supplements

What are the most common side effects of OPDIVO?

The most common side effects of OPDIVO when used alone include:

  • feeling tired
  • pain in muscles, bones, and joints
  • diarrhea
  • weakness
  • shortness of breath
  • decreased appetite
  • upper respiratory tract infection
  • headache
  • rash
  • itchy skin
  • nausea
  • cough
  • constipation
  • back pain
  • fever
  • stomach pain

These are not all of the possible side effects of OPDIVO. Talk to your healthcare team for more information. Call your doctor
for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit
www.fda.gov/medwatch or call
1-800-FDA-1088. You may also report
side effects to Bristol-Myers Squibb
at 1-800-721-5072.


For more information, please see U.S. Full Prescribing Information and Medication Guide for OPDIVO, or talk to your healthcare team.